Viatris
Pharma0
Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
0
Indications↗
Distinct diseases across all programs
3
Clinical Trials↗
All sponsored trials (all statuses)
Activity
Key Events
Apr 1, 2024TrialA Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions
Mar 1, 2024TrialA Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions
Jul 23, 2023TrialSafety and Efficacy Evaluation of <Dovprela Tablets 200 mg> by Post-marketing Surveillance
Regulatory
Regulatory Timeline
20011 event
FDAFeb 16
Foradil — FORADIL
Application NDA020831 (NDA)
20061 event
FDADec 15
Foradil — FORADIL CERTIHALER
Application NDA021592 (NDA)
20071 event
FDAMay 11
Foradil — PERFOROMIST
Application NDA022007 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)